PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 50 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $69,000 | -23.3% | 62,982 | -4.1% | 0.00% | – |
| Q2 2020 | $90,000 | – | 65,686 | +28583.8% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 229 | -97.0% | 0.00% | – |
| Q2 2019 | $8,000 | -89.6% | 7,706 | -87.3% | 0.00% | – |
| Q1 2019 | $77,000 | -64.7% | 60,890 | -10.0% | 0.00% | – |
| Q4 2018 | $218,000 | +175.9% | 67,633 | +104.1% | 0.00% | – |
| Q3 2018 | $79,000 | -16.0% | 33,138 | -1.8% | 0.00% | – |
| Q2 2018 | $94,000 | +224.1% | 33,745 | +462.4% | 0.00% | – |
| Q1 2018 | $29,000 | -17.1% | 6,000 | 0.0% | 0.00% | – |
| Q4 2017 | $35,000 | +52.2% | 6,000 | -43.7% | 0.00% | – |
| Q3 2017 | $23,000 | +64.3% | 10,665 | +255.5% | 0.00% | – |
| Q2 2017 | $14,000 | -70.2% | 3,000 | -49.8% | 0.00% | – |
| Q1 2017 | $47,000 | +74.1% | 5,980 | +174.3% | 0.00% | – |
| Q4 2016 | $27,000 | -20.6% | 2,180 | 0.0% | 0.00% | – |
| Q3 2016 | $34,000 | – | 2,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|